Researchers developing new approach for imaging dense breasts for abnormalities

January 24, 2014
This photo shows an overview of the MRI/near-infrared spectroscopy (NIRS) system. The NIRS system is housed in the MRI control room (a) and light is piped into the MRI suite for patient imaging using fiber optic cables (b). A combined MRI/NIRS breast coil (c) makes simultaneous MRI and NIRS imaging possible. Credit: Photo courtesy of Norris Cotton Cancer Center

Dartmouth engineers and radiologists are developing new approaches for an emerging technique in diagnostic imaging for breast cancer—MRI with near-infrared spectroscopy (NIRS) as reported in the journal Academic Radiology, February 2014.

Combined MRI/NIRS may benefit women whose mammogram showed an abnormality and requires further testing to rule out cancer. The test would be conducted before an invasive biopsy to look for tumors. For the new method to work successfully in routine patient care, MRI/NIRS must adapt to an individual's body size as well as accommodate a range of cup sizes. The equipment must also mobilize and maintain contact with the .

An MRI/NIRS may offer specific advantages to women with , who are more likely to develop and die from . A dense breast is harder for a radiologist to "see through" when using traditional imaging equipment, which lacks the sensitivity to penetrate the dense tissue. Standard is effective 77-97 percent of the time in a normal breast, but when a breast is dense precision falls to 63-89 percent.

Prior approaches for MRI/NIRS used parallel plates and relied on custom breast molds for each patient. Biomedical engineers from the Thayer School of Engineering at Dartmouth developed a new, more flexible, convenient, and comfortable approach. They designed a set of eight light transmitting cables that can be adjusted to surround the breast with light tension. A woman lies on her stomach and the breast hangs pendant through the holes of the MRI/NIRS breast coil. The procedure is nearly identical to clinical MRI.

Eight women participated in a trial of the new design. "We found that the new interface allowed us to target lesions more effectively than ever before, said Michael Mastanduno, corresponding author of the study. "Set up time was faster and images were of higher quality."

The Dartmouth MRI/NIRS offers increased coverage of the chest, giving providers improved visibility for " hard to see" areas, such as the outside area of the breast near the armpit.

"This work is a huge improvement on previous designs of MRI/NIRS systems. All breast sizes and lesion locations can now be effectively imaged. Though there is more work to be done, this technology is promising for improving MRI's ability to distinguish cancer from benign abnormalities," said Mastanduno.

As a next step Dartmouth researchers will test MRI/NIRS in women with suspicious lesions.

Explore further: Preop MRI valuable in detecting additional malignancies in dense & not dense breasts

Related Stories

Preop MRI valuable in detecting additional malignancies in dense & not dense breasts

May 4, 2012
Newly diagnosed breast cancer patients should undergo a preoperative MRI exam even if their breasts are not dense, a new study indicates. The study found no difference between the usefulness of 3T breast MRI in detecting ...

Growing use of MRIs leading to more invasive breast cancer surgery

August 14, 2013
Heavy use of magnetic resonance imaging (MRI) may be leading to unnecessary breast removal in older women with breast cancer, according to a study by Yale School of Medicine researchers in the current issue of Breast Cancer ...

New breast cancer imaging technique could cut down on false positives

September 27, 2013
(Medical Xpress)—A joint BYU-Utah research team is developing a new breast cancer screening technique that has the potential to reduce false positives, and, possibly, minimize the need for invasive biopsies.

MRI right before or after surgery does not benefit women with early breast cancer

September 4, 2013
Memorial Sloan-Kettering Cancer Center study shows that the use of MRI before or immediately after surgery in women with DCIS was not associated with reduced local recurrence or contralateral breast cancer rates. The findings ...

Two new studies on the use of breast MRI

November 18, 2013
The overall use of breast magnetic resonance imaging has increased, with the procedure most commonly used for diagnostic evaluations and screenings, according to a study published by JAMA Internal Medicine.

Individualized breast cancer screening catches more cancer

August 12, 2013
(HealthDay)—A breast cancer screening program tailored to participants' individual risk profiles has a higher-than-expected breast cancer detection rate in 40- to 49-year old women, according to a pilot study published ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.